GDOC Among Gold ETFs
End-of-day Nov 17, 2026 · 35 Gold ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −2.6% | +4.1% | −0.7% | +8.1% | +7.0% | +35.7% | — | — | −0.8% |
| Peer average | −0.7% | −3.7% | −5.5% | −10.3% | −0.7% | +2.1% | +87.7% | +73.3% | +198.5% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$145 of every $1,000 in GDOC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.47% | $1,447.50 | 2,066 | $3.0M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.29% | $628.87 | 4,548 | $1.3M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 5.87% | $587.16 | 2,912 | $1.2M |
| 4 | EWEdwards Lifesciences | Healthcare | 4.85% | $484.55 | 9,244 | $990K |
| 5 | MRKMerck | Healthcare | 4.82% | $481.51 | 6,811 | $984K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.98% | $397.67 | 1,511 | $813K |
| 7 | AAgilent Technologies | Healthcare | 3.80% | $379.54 | 4,485 | $776K |
| 8 | TMOThermo Fisher Scientific | Healthcare | 3.77% | $376.89 | 1,114 | $770K |
| 9 | AZN.LAstrazeneca ORD | Healthcare | 3.42% | $342.13 | 3,778 | $699K |
| 10 | DXCMDexcom | Healthcare | 3.32% | $332.17 | 8,317 | $679K |
| 11 | GHGuardant Health | Healthcare | 3.11% | $310.91 | 4,411 | $635K |
| 12 | GILDGilead Sciences | Healthcare | 3.08% | $308.03 | 3,756 | $629K |
| 13 | ABBVAbbvie | Healthcare | 3.03% | $302.85 | 2,101 | $619K |
| 14 | LONN.SWLonza Group AG | Healthcare | 3.01% | $301.35 | 771 | $616K |
| 15 | CORCencora | Healthcare | 2.83% | $282.81 | 1,619 | $578K |
of the $261B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.47% |
| 2 | JNJ | Johnson & Johnson | 6.29% |
| 3 | UNH | Unitedhealth Group Incorporated | 5.87% |
| 4 | EW | Edwards Lifesciences | 4.85% |
| 5 | MRK | Merck & | 4.82% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 3.98% |
| 7 | A | Agilent Technologies | 3.80% |
| 8 | TMO | Thermo Fisher Scientific | 3.77% |
| 9 | AZN.L | Astrazeneca ORD | 3.42% |
| 10 | DXCM | Dexcom | 3.32% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |